Navigation Links
'Superbug' Outbreak Calls for Immediate Increased Attention on Infection Control
Date:10/31/2007

NEW YORK, Oct. 31 /PRNewswire/ -- A recent outbreak of MRSA (Methicillin- resistant Staphylococcus aureus) bacteria, often referred to as "the superbug," should cause organizations and facilities nationwide to reevaluate and redouble their infection control efforts.

The superbug is resistant to common antibiotics. It manifests its symptoms as skin infections such as abscesses, boils and other pus-filled lesions. Superbug infections prior to 2007 were most frequently found in hospital and healthcare facilities (nosocomial infections) and were referred to as HAIs (Hospital Acquired Infections). However, recent outbreaks are being categorized as Community-Assisted (CA)-MRSA infections, which occur in otherwise healthy people who have not been hospitalized or had a medical procedure within the past year. Workout facilities, school gymnasiums, manufacturing facilities and even office buildings have all been affected, requiring the immediate decontamination and disinfection of affected areas.

LVI Services Inc. specializes in infection control (http://www.lviservices.com/SERVICE/infection.asp) and has recently completed several successful superbug emergency response cleanups, which involved neutralizing and reducing the potential for transmission of infectious agents. LVI's means and methods of remediation include infection control containments, negative air pressure, and materials and processes that destroy and remove the bacteria.

"Our technicians determine potential areas of MRSA contamination and isolate and restrict the areas as a first order of business," said Al Draper, director of restoration for New York City-based LVI Services. "Our focus is on tackling infected sites to contain and destroy these bacteria and keep people safe and healthy."

The superbug scare has reinforced the urgency for proper infection control procedures in healthcare settings - a first line of defense against MRSA-type infections reaching the general public. According to the Centers for Disease Control and Prevention, the superbug caused more than 94,000 life-threatening infections and nearly 19,000 deaths in the United States in 2005, most of them associated with healthcare settings.

LVI's infection control capabilities are employed in a range of facility- based services on a national scale. LVI works in concert with healthcare facility administrators and general contractors to design and implement engineering controls and physical barriers to prevent airborne contaminants from escaping work zones. These measures reduce the potential for the inadvertent cross-contamination of patient treatment areas.

About LVI Services

LVI Services Inc. is the United States' leading provider of a wide array of integrated facility services, including environmental remediation, demolition and related services for commercial, industrial, multi-family residential and governmental facilities. LVI focuses on projects involving asbestos, lead paint, mold, infection control, hazardous materials, emergency and disaster services, and demolition. Founded in 1986, LVI has more than 30 offices across the United States, is licensed in every state, and is experienced in responding to natural and manmade disasters around the world. The company's annual revenues exceed $300 million. For more information, visit http://www.lviservices.com.


'/>"/>
SOURCE LVI Services Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
2. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
3. Infertile Voice Supports Stem Cell Research: RESOLVE Calls for Patient Options in Using Frozen Embryos
4. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
5. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation
6. Immediate Treatment of Early MS Patients with Betaferon Significantly Delayed Permanent Disability
7. First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron Significantly Delayed Permanent Disability
8. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
9. Blood Levels of Paliperidone Extended-Release Tablets are Not Increased by Common Antidepressant
10. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
11. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research and Markets ... Report" report to their offering. ... This report analyzes the worldwide markets for ... US, Canada , Japan , ... , and Rest of World. Annual estimates and forecasts are provided ...
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX , ... Nationwide Children,s Hospital signed a membership agreement ... the development of new cures. The ... over 57 million patients globally, biopharmaceutical companies and ... to improve protocol design, site selection, patient recruitment, ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... NJ (PRWEB) , ... December 08, 2016 , ... CURE ... cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to ... making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... 08, 2016 , ... Today’s patients are encouraged to be ... SIGVARIS has created a new line of anti-embolism stockings to help prevent a ... benefits of graduated compression when transitioning from recovery to early rehabilitation. , The ...
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
Breaking Medicine News(10 mins):